Low values for complement (C3) in serum can be used in classifying systemic lupus erythematosus
Manu, P.
Clinical Chemistry 30(5): 820
1984
ISSN/ISBN: 0009-9147 PMID: 6713657 Document Number: 232178
Document emailed within 1 workday
Related Documents
Sullivan, K.E.; Wisnieski, J.J.; Winkelstein, J.A.; Louie, J.; Sachs, E.; Choi, R.; Veksler, E.; Goldman, D.; Petri, M. 1996: Serum complement determinations in patients with quiescent systemic lupus erythematosus Journal of Rheumatology 23(12): 2063-2067Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Schur, P.H. 1988: Systemic lupus erythematosus and complement Nephrologie 9(2): 53-60
Singh, V.; Mahoney, J.A.; Petri, M. 2008: Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus Journal of Rheumatology 35(10): 1989-1993
Yukiyama, Y.; Tokunaga, K.; Yoshida, K.; Miyamoto, T. 1985: Studies of genetic polymorphism of complement C2, B and C6 in systemic lupus erythematosus Ryumachi 25(4): 274-277
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Hunder, G.G.; McDuffie, F.C.; Hepper, N.G. 1972: Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis Annals of Internal Medicine 76(3): 357-363
Ueda, A.; Kusaba, T.; Yanase, T. 1983: Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus Clinical and Experimental Immunology 53(1): 217-224
Pigrau, A.; Martínez-Vázquez, J.M.; Bacardí, R.; Ocanña, I.; Pahissa, A. 1984: Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus Medicina Clinica 83(19): 787-791
Jongen, P.J.; Boerbooms, A.M.; Lamers, K.J.; Raes, B.C.; Vierwinden, G. 1990: Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement Neurology 40(10): 1593-1596
Tsuge, I.; Kondo, Y.; Nakajima, Y.; Nakagawa, N.; Imai, K.; Nonoyama, S.; Oshima, K.; Ohara, O.; Hatanaka, M.; Kitano, E.; Kitamura, H.; Urisu, A. 2010: Hyper IgM syndrome and complement Clq deficiency in an individual with systemic lupus erythematosus-like disease Clinical and Experimental Rheumatology 28(4): 558-560
Shrier, D.A.; Taniguchi, O.; Barnett, E.V. 1984: Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera Journal of Rheumatology 11(2): 182-187
Yoshida, K.; Yukiyama, Y.; Miyamoto, T. 1987: Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus Journal of Rheumatology 14(3): 490-496
Davis, P.; Cumming, R.H.; Verrier-Jones, J. 1977: Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus Clinical and Experimental Immunology 28(2): 226-232
Arvieux, J.; Roussel, B.; Ponard, D.; Colomb, M.G. 1991: Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation Clinical and Experimental Immunology 84(3): 466-471
Huber, C.; Pfister, R.; Stingl, G. 1982: Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML Clinical and Experimental Immunology 50(3): 525-533
Luis M. Amezcua-Guerra; Springall, R.; Arrieta, A.A.-Alvarado; Verónica Rodriguez; Rivera, E.-Martinez; Castillo, D.-Martinez; Bojalil, R. 2011: C-Reactive Protein and Complement Components but not Other Acute-Phase Reactants Discriminate Between Clinical Subsets and Organ Damage in Systemic Lupus Erythematosus Clinical Laboratory 57(7-8): 607-613
Folomeev, M.I.; Nasonov, E.L.; Prokaeva, T.V.; Masenko, V.P.; Ovtrakht, N.V. 1990: The serum prolactin levels of men with systemic lupus erythematosus and rheumatoid arthritis Terapevticheskii Arkhiv 62(1): 62-63
Alpa, M.; Ferrero, B.; Cavallo, R.; Naretto, C.; Gennaro, M.; Bellizia, L.; Sena, L.M.; Roccatello, D. 2002: Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(6): 617-621
Daha, M.R.; Hazevoet, H.M.; van Es, L.A. 1984: Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus Clinical and Experimental Immunology 56(3): 614-620